Nvidia-Backed Recursion, Ginkgo Bioworks Rally Following FDA’s Decision To End Animal Testing – Absci (NASDAQ:ABSI), Charles River (NYSE:CRL)

The U.S. Food and Drug Administration (FDA) announced its plans to end the mandatory animal testing of new drugs, a move that sent AI-enabled biotech companies such as Recursion Pharmaceuticals Inc. RXRX and Ginkgo Bioworks Holdings Inc. DNA…